论文部分内容阅读
目的探讨普米克令舒辅助复方异丙托溴胺雾化吸入治疗小儿毛细支气管炎的临床疗效。方法回顾性分析98例毛细支气管炎患儿的临床资料。结果观察组总有效率93.88%,明显优于对照组的73.47%,两组比较差异具有统计学意义(P<0.01)。结论普米克令舒辅助复方异丙托溴胺雾化吸入治疗小儿毛细支气管炎疗效显著,安全性高,适合临床推广使用。
Objective To investigate the clinical efficacy of Pulmicort respules assisted with Ipratropium bromide inhalation in children with bronchiolitis. Methods The clinical data of 98 children with bronchiolitis were retrospectively analyzed. Results The total effective rate in the observation group was 93.88%, which was significantly better than that in the control group (73.47%). The difference between the two groups was statistically significant (P <0.01). Conclusions Pulmicort respules Compound Ipratropium bromide inhalation treatment of children with bronchiolitis significant effect, high safety, suitable for clinical use.